GenBioPro, Inc. v. Raynes et al
Case Number:
3:23-cv-00058
Court:
Nature of Suit:
Judge:
Firms
-
February 08, 2024
Drugmaker Challenges W.Va. Abortion Ban In 4th Circ.
GenBioPro, which makes generic mifepristone, a drug used to end early pregnancies, is urging the Fourth Circuit to reverse a lower court's finding that West Virginia's ban on most abortions is not an unconstitutional obstacle to federal law.Â
-
August 24, 2023
W.Va. AG Knocks Out Bulk Of Challenge To Abortion Pill Ban
A West Virginia federal judge on Thursday axed GenBioPro's challenge to a state law severely restricting access to medication abortions, saying the U.S. Supreme Court has repeatedly affirmed that morality-based product bans are not intrinsically unconstitutional, but allowed the pharmaceutical company's claim over telemedicine prescribing restrictions to proceed.
-
June 22, 2023
Abortion Litigation To Watch As Dobbs Decision Turns 1
The U.S. Supreme Court's elimination of the constitutional right to abortion hit like an earthquake last summer, uprooting long-standing reproductive rights, triggering state laws curbing abortion access and flooding courts with litigation. A year later, legal battles promise further shake-ups to the abortion landscape.
-
May 03, 2023
W. Va. Abortion Drug Law Fight Can Continue, Judge Rules
A West Virginia federal judge shot down requests to throw out GenBioPro's lawsuit against a West Virginia law that limits the use of a drug used in medication abortions, finding that the adequate standing requirements were met.
-
January 25, 2023
Abortion Drug Restrictions Draw Challenges In W.Va., NC
Drugmaker GenBioPro has launched a lawsuit against a West Virginia law that limits the use of a drug used in medication abortions, the same day a legal attack was directed at a similar North Carolina law.